ZYDUS LIFESCIENCES
|
The Current P/S Ratio of ZYDUS LIFESCIENCES is 4.12.
| Share Price | ₹1,120.7 | Aug 10,2026 |
| Market Cap | ₹111,789.8 Cr | |
| Sales-TTM | ₹27,148.4 Cr | TTM-Consolidated Results |
| Price/Sales | 4.12x | Calculated as Market Cap/Sales |
|---|---|---|
| Explore Stock Analytics | ||
Definition & Calculation of PS (Price/Sales) ratio of ZYDUS LIFESCIENCES
P/S =
Market Capitalization
/
Sales
or, using per-share numbers:
P/S = Stock Price / Sales Per Share
Current Market Cap [ ₹111,789.8 Cr] as on Aug 10,2026
(/) Sales [ ₹27,148.4 Cr] based on TTM-Consolidated Results
(=) P/S Ratio [ 4.12x ]
Thus, for ZYDUS LIFESCIENCES , the investors are currently willing to pay '4.12 times sales' to own 1 share of the company.
PS Multiples are one of the most widely used valuation multiple in the industry.
P/S ratios can be a reliable benchmark to compare companies with negative earnings or book value.
You may also explore Price to Earnings ratio or Price to Book ratio of ZYDUS LIFESCIENCES !
The chart below summarizes the trend in P/S Ratio of ZYDUS LIFESCIENCES over the last five years.
Historical PS (Price/Sales) ratio chart of ZYDUS LIFESCIENCES
PS Ratio Performance Analysis for ZYDUS LIFESCIENCES
- ZYDUS LIFESCIENCES 's p/e ratio for fiscal years ending Mar2026 to Mar2022 averaged 3.50x.
- ZYDUS LIFESCIENCES 's operated at median p/e ratio of 3.23x from fiscal years ending March 2018 to 2022.
- Looking back at the last 5 fiscal years, ZYDUS LIFESCIENCES 's p/e ratio peaked in Mar2024 at 5.17x.
- ZYDUS LIFESCIENCES 's p/e ratio hit its five-year low in Mar2022 of 2.36x.
How does ZYDUS LIFESCIENCES 's P/S Ratio benchmark against top 10 peers in Pharmaceuticals & Drugs Industry?
| Peer Comparison (Pharmaceuticals & Drugs Industry) | Sales (Cr) | PS Ratio | Market Cap (Cr) |
|---|---|---|---|
| ZYDUS LIFESCIENCES | 27,148.4 | 4.12 | 111,789.8 |
| SUN PHARMACEUTICAL INDUSTRIES LTD | 59,910.5 | 7.82 | 468,530.0 |
| DIVIS LABORATORIES LTD | 11,230.0 | 19.56 | 219,675.0 |
| TORRENT PHARMACEUTICALS LTD | 15,723.0 | 11.89 | 186,970.0 |
| CIPLA LTD | 28,324.4 | 4.16 | 117,947.0 |
| DR REDDYS LABORATORIES LTD | 33,227.9 | 2.91 | 96,601.2 |
| MANKIND PHARMA LTD | 14,737.9 | 6.83 | 100,688.0 |
| LUPIN LTD | 29,966.6 | 3.47 | 104,021.0 |
| AUROBINDO PHARMA LTD | 34,935.3 | 2.71 | 94,707.2 |
| LAURUS LABS LTD | 7,269.6 | 13.87 | 100,822.0 |
| BIOCON LTD | 17,321.1 | 4.05 | 70,076.9 |
Pharmaceuticals & Drugs Industry Benchmark (Top 10) PS Analysis vs ZYDUS LIFESCIENCES 's P/S Ratio
| Top 10 Industry Peers | PS Ratio |
|---|---|
| Min industry PS | 2.71x |
| Max industry PS | 19.56x |
| Median industry PS | 4.16x |
| Average industry PS | 7.40x |
You may also like the below Video Courses